Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.42 |
| ▸ | SMARCA2 | P51531 | 3/20 | 0.42 |
| ▸ | SMARCA4 | P51532 | 3/20 | 0.42 |
| ▸ | PBRM1 | Q86U86 | 3/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 6/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.39 |
| ▸ | MAPT | P10636 | 6/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27651172 | 0.98 | IDO1 (0.42) | IDO1NR1I2SMARCA2SMARCA4PBRM1 | |
| SCHEMBL28691784 | 0.92 | HPGD (0.38) | IDO1NR1I2SMARCA2SMARCA4PBRM1 | |
| SCHEMBL6135309 | 0.76 | GPR55 (0.39) | NR1I2SMARCA2SMARCA4PBRM1BRD4 | |
| SCHEMBL6348373 | 0.76 | CASP3 (0.35) | CASP3SENP8SENP7SENP6 | |
| SCHEMBL7736978 | 0.76 | — | — | |
| SCHEMBL5152908 | 0.76 | ALDH1A1 (0.52) | IDO1HPGDHSD17B10ALDH1A1SMN1; SMN2 | |
| SCHEMBL2679546 | 0.76 | RAB9A (0.48) | IDO1HPGDHSD17B10ALDH1A1SMN1; SMN2 | |
| SCHEMBL7903481 | 0.76 | ENPP2 (0.33) | — | |
| SCHEMBL2200428 | 0.74 | GPR55 (0.38) | NR1I2SMARCA2SMARCA4PBRM1BRD4 | |
| SCHEMBL3062578 | 0.73 | ENPP3 (0.44) | HPGDHSD17B10ALDH1A1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1676 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12528892-B2 | Alkylation of transition metal coordination catalyst complexes | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2026-01-20 | — | — | US | claimed |
| US-20230141606-A1 | Alkylation of Transition Metal Coordination Catalyst Complexes | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-05-11 | — | — | US | claimed |
| WO-2021194831-A1 | ALKYLATION OF TRANSITION METAL COORDINATION CATALYST COMPLEXES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-09-30 | — | — | WO | claimed |
| CN-113948650-B | Light emitting device and electronic apparatus including the same | 三星显示有限公司 | 2026-05-22 | — | — | CN | disclosed |
| US-12635330-B2 | Light-emitting device and electronic apparatus including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| US-12635404-B2 | Organometallic compound and light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| US-12630576-B2 | Light-emitting device including organometallic compound, electronic apparatus including the light-emitting device, and the organometallic compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| US-12635410-B2 | Light-emitting device and electronic apparatus including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| US-12630732-B2 | Scattering particle, ink composition including the same, and display apparatus including quantum dot layer prepared by using the ink composition | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| CN-122037923-A | Quantum dot, optical member and electronic device comprising the same, and method for preparing the quantum dot | 三星显示有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260132332-A1 | QUANTUM DOT, OPTICAL MEMBER AND ELECTRONIC APPARATUS INCLUDING THE QUANTUM DOT, AND METHOD FOR PREPARING QUANTUM DOT | SAMSUNG DISPLAY CO LTD (KR) | 2026-05-14 | — | — | US | disclosed |
| EP-3219714-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2017-09-20 | — | — | EP | disclosed |
| US-7402583-B2 | Substituted quinolines as antitumor agents | ASTRZENCA AB (SE) | 2008-07-22 | — | — | US | disclosed |
| US-20070021407-A1 | Substituted quinolines as antitumor agents | ASTRAZENECA | 2007-01-25 | — | — | US | disclosed |
| US-7067532-B2 | Substituted quinolines as antitumor agents | ASTRAZENECA (SE) | 2006-06-27 | — | — | US | disclosed |
| US-20040029898-A1 | Substituted quinolines as antitumor agents | ASTRAZENECA AB (SE) | 2004-02-12 | — | — | US | disclosed |
| EP-1337524-A1 | SUBSTITUTED QUINOLINES AS ANTITUMOR AGENTS | AstraZeneca AB (SE) | 2003-08-27 | — | — | EP | disclosed |
| WO-2002044166-A1 | SUBSTITUTED QUINOLINES AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2002-06-06 | — | — | WO | disclosed |
| US-5643929-A | TREATMENT OF PICORNAVIRAL OR RHINOVIRUS AND CHEMICAL INTERMEDIATES | SANOFI WINTHROP, INC. (US) | 1997-07-01 | — | — | US | disclosed |
| US-5464848-A | 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents | STERLING WINTHROP INC. (US) | 1995-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528892-B2 | Alkylation of transition metal coordination catalyst complexes | LEF1, TAF1, FLI1 | IDO1 1515/4885NR1I2 3252/4885SMARCA2 342/4885 |
| US-20070021407-A1 | Substituted quinolines as antitumor agents | NR1H3, NR1H2, NR0B1 | IDO1 1856/4885NR1I2 21/4885SMARCA2 2674/4885 |
| US-12630732-B2 | Scattering particle, ink composition including the same, and display apparatus including quantum dot layer prepared by using the ink composition | IK, INCENP, TYR | IDO1 290/4885NR1I2 4368/4885SMARCA2 1481/4885 |
| US-20040029898-A1 | Substituted quinolines as antitumor agents | NQO2, NQO1, TP53 | IDO1 122/4885NR1I2 1210/4885SMARCA2 3381/4885 |
| US-12635330-B2 | Light-emitting device and electronic apparatus including the same | L1CAM, EEA1, PAX3 | IDO1 759/4885NR1I2 3443/4885SMARCA2 2549/4885 |
| US-20230141606-A1 | Alkylation of Transition Metal Coordination Catalyst Complexes | AS3MT, AP1M1, AP3M1 | IDO1 3115/4885NR1I2 4106/4885SMARCA2 582/4885 |
| US-12635410-B2 | Light-emitting device and electronic apparatus including the same | CYBA, RPL21, CYC1 | IDO1 1892/4885NR1I2 672/4885SMARCA2 3703/4885 |
| US-12630576-B2 | Light-emitting device including organometallic compound, electronic apparatus including the light-emitting device, and the organometallic compound | ZC3HAV1L, SOD1, GPS1 | IDO1 1462/4885NR1I2 1014/4885SMARCA2 4510/4885 |
| US-20260132332-A1 | QUANTUM DOT, OPTICAL MEMBER AND ELECTRONIC APPARATUS INCLUDING THE QUANTUM DOT, AND METHOD FOR PREPARING QUANTUM DOT | SOD3, SOD1, YBX3 | IDO1 2524/4885NR1I2 3277/4885SMARCA2 2190/4885 |
| US-12635404-B2 | Organometallic compound and light-emitting device including the same | SOD1, GPS1, SLC39A11 | IDO1 482/4885NR1I2 889/4885SMARCA2 4295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.